Biocon and Mylan's Herceptin biosimilar approved in india
The Drug Controller General of India has approved a biosimilar version of Roche’s Herceptin developed by Biocon and Mylan.
Archives for December 2, 2013
Cobra says the right tech strategy can cut lead times
Choosing the same biomanufacturing tech supplier for development and commercial systems cuts scale steps and reduces lead times according to Cobra Biologics.
Dispatches from AAPS
Almac launches 'unique' radiolabeling service for ADCs; names Pfizer client
Almac says it is in a unique position to offer Carbon-14 ADME radiolabeling for the growing antibody-drug conjugate (ADC) market and has already performed the service on a Pfizer candidate.